CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule

Peer Review reports

Original Submission
29 Apr 2022	Submitted	Original manuscript
31 May 2022	Reviewed	Reviewer Report
26 Aug 2022	Reviewed	Reviewer Report
23 Sep 2022	Author responded	Author comments - Hiroaki Nagano
Resubmission - Version 2
23 Sep 2022	Submitted	Manuscript version 2
26 Sep 2022	Author responded	Author comments - Hiroaki Nagano
Resubmission - Version 3
26 Sep 2022	Submitted	Manuscript version 3
3 Oct 2022	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
6 Oct 2022	Editorially accepted
18 Oct 2022	Article published	10.1186/s12885-022-10181-7

Back to article page